DKBIO2019

New York, April 10 – April 11, 2019

DKBIO is a leading life sciences conference where innovators, business developers, and investors can have thoughtful discussions around the realities of international business and medical development. The two day meeting brings together leaders from Denmark, Europe, and the US and aims to drive international investment and collaboration.

We are very excited about our 2019 program! With a special focus this year on data, clinical trials, and the future of personalized medicine, we are looking forward to bringing some strong forecasting to DKBIO as to where our industry is going.

 

Investors and business development leaders can request 1x1 now with 20 companies with Danish innovation for biotech and medical device. 

Materials

General Agenda

Starting with Breakfast on April 10th, our program begins at 8 am. The second day, April 11th, will also begin at 8 am.

Evening reception on the 10th by invitation only. 

Wednesday April 10

1251 Avenue of the Americas, 20th Floor, McGuireWoods LLP, New York City

8:00 AM

Breakfast and Registration

Kick-off Sponsored by EY

8:30 – 8:40AM

Welcome to DKBIO2019

Ambassador, Consul General of Denmark in New York, Anne Dorte Riggelsen

8:40 – 9:30 AM

Our Patient Collaborators: Living the Clinical Trial

Patients from Parkinson’s Foundation, National Psoriasis Foundation, JDRF, and an oncology patient will share their experiences from trials

• Moderated by Avital Gaziel, Co-founder Trialjectory

9:40 – 10:00 am

Networking Coffee Break

Sponsored by Clinical Survey Outcomes

10:00 – 11:15 pm

Danish Company Presentations, Hosted by EY

Afyx, Nishan de Silva, CEO

Galecto, Jakob Dynnes Hansen, CFO

STipe Therapeutics, Martin R. Jakobsen, CEO

SNIPR Biome, Eric van der Helm, CSO

Acesion Pharma, Frans Wuite, CEO

11:15 – 12:00 pm

Fireside chat: Getting from the Clinic to Value, Lessons from Novartis

 With Leigh Anne Leas, US Country Head, Public Policy, Novartis

 Moderated by Kate W. Hardey, Partner, McGuireWoods LLP

12:00 – 1:00 pm

Agern Networking Lunch

Sponsored by Lundbeckfonden

1:00 – 2:00 pm

Investing, and Growing, Abroad

• Iain Dukes, Venture Partner Orbimed

• Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA)

• Thomas Pedersen, CEO NMD Pharma

• Noël Kurdi, Director of Investor Relations, Nanobiotix

Moderated by  Jonathan Gertler M.D., Managing Partner and CEO, Back Bay Life Science Advisors

2:00 – 2:30

Fireside chat: From Private to Public, What Changes

With Anders Hinsby, CEO, Orphazyme

Moderated by  Carsten Borring, Head of Listings & Capital Markets, Nasdaq Copenhagen

2:30 – 3:30 pm

Danish Company Presentations, Hosted by Solebury Trout

IO Biotech, Søren Bregenholdt, CBO

Serodus, Eva Steiness, CEO

InProTher, Peter Johannes Holst, CEO & Founder

 

2:30 – 5:00 **1x1 Meetings on 20th floor**

Reception is from 6:00 – 8:00 pm with keynote from Tony Wong,  Head of Global Research and Credit Strategy, Invesco

 

 

 

Thursday April 11

 

1251 Avenue of the Americas, 20th Floor, McGuireWoods LLP, New York City

8:00 am

Networking Breakfast

Sponsored by Back Bay Life Science Advisors

8:30 – 8:45 am

DKBIO, Innovation, and Denmark: Where We are Going

Joan Hentze, Head of Innovation Center Boston and Head of Life Sciences North America Denmark

Thomas Nagy, Director at the BioInnovation Institute

8:45 – 9:45 am

Functionalizing Data for Health, with Wired Magazine

• Morten Sogaard, Vice President Target Sciences, Pfizer Inc.

• Olivier Elemento, Director, Englander Institute for Precision Medicine, Weill Cornell Medical College

• Aris Baras, Senior Vice President, Regeneron Genetics Center

• Elin Rønby Pedersen, Google Research - HCI and AI in Health

Moderated by Louise Matsakis, Wired Magazine

9:45 – 10:45 am

Danish Company Presentations, Hosted by Back Bay Life Science Advisors

NMD Pharma, Thomas Pedersen, CEO

Medtrace Pharma, Martin Stenfeldt, CEO

RetiPharma, Henrik Vissing, CEO

10:45 – 11:15 am

Networking Coffee Break

Sponsored by McGuireWoods LLP

11:15 am – 12:00 pm

New Science, New Frontier: How new discoveries are changing the landscape

• Bob Silverman, Personalized Healthcare (PHC) Business Strategy & Partnering, Roche

• Sam Hall, Partner, Apple Tree Partners

• Andreas Jurgeit, Partner, Lundbeckfonden Emerge

• Christian Grøndahl, CEO, SNIPR Biome

• Maria Pineda, CEO, Envisagenics

Moderated by Irene Hudson, Partner, McGuireWoods LLP

12:00 – 1:00 pm

Brownsville Culinary Networking Lunch

Sponsored by Novo Group

1:00  – 2:00 pm

Danish Company Presentations, Hosted by Novo Group

Forward Pharma, Claus Bo Svendsen, CEO

Insusense Therpauetics,  Anders Nykjaer, CSO

Synklino, Thomas Kledahl, CEO

Circle Biomedical, Frederik Petursson Madsen, CEO

2:00 - 2:45 pm

The ABCs of Financial Tools in the Toolbelt

• Mette Dyhrberg, CEO Mymee

• Pedro Gonzalez de Cosio, CEO Pharmakon Advisors

• Greg Benning, Managing Director and Group Head M&A, Back Bay Life Science Advisors

• Lee Stettner, Managing Director, Solebury Capital

• Barrett Polan, HayFin Advisors LLC

• Amanda Hayward, Connecticut Innovations

Moderated by Seth Goldsamt, Partner, McGuireWoods LLP

2:30 – 5:00 **1x1 Meetings on 20th floor**

 

Thank You to our Sponsors!

 

 

RSVP for Event / Log Back in Participating Companies

Additional menu options can be found in the menu bar on the left or at the top.

Event Contact

Megan Dow, PhD
Royal Danish Consulate

Location of the Event and Other Places